Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Höhn H[au]:

Michael Schmid (1948-2018): A Life Devoted to Science. Höhn H et al. Cytogenet Genome Res. (2018)

Michael Schmid (1948-2018): A Life Devoted to Science. Höhn H et al. Sex Dev. (2018)

[Not Available]. Riemann JF et al. Z Gastroenterol. (2016)

Search results

Items: 1 to 50 of 99

1.

Michael Schmid (1948-2018): A Life Devoted to Science.

Höhn H.

Sex Dev. 2018 Oct 31. doi: 10.1159/000494234. [Epub ahead of print] No abstract available.

2.

Michael Schmid (1948-2018): A Life Devoted to Science.

Höhn H.

Cytogenet Genome Res. 2018 Oct 17. doi: 10.1159/000494232. [Epub ahead of print] No abstract available.

3.

PillCamColon2 after incomplete colonoscopy - A prospective multicenter study.

Baltes P, Bota M, Albert J, Philipper M, Hörster HG, Hagenmüller F, Steinbrück I, Jakobs R, Bechtler M, Hartmann D, Neuhaus H, Charton JP, Mayershofer R, Hohn H, Rösch T, Groth S, Nowak T, Wohlmuth P, Keuchel M.

World J Gastroenterol. 2018 Aug 21;24(31):3556-3566. doi: 10.3748/wjg.v24.i31.3556.

4.

Kolonkapsel als Vorsorge – Untersuchung Positionspapier der Stiftung Lebensblicke.

Riemann JF, Albert J, Altenhofen L, Aschenbeck J, Dahlhoff G, Dignaß A, Hohn H, Hüppe D, Jung M, Khoury M, Munte A, Neuhaus H, Philipper M, Rösch T, Zillinger C, Belle S.

Z Gastroenterol. 2016 Mar;54(3):259. German. No abstract available.

PMID:
27500297
5.

Effect of the stiffness of bone substitutes on the biomechanical behaviour of femur for core decompression.

Tran TN, Kowalczyk W, Hohn HP, Jäger M, Landgraeber S.

Med Eng Phys. 2016 Sep;38(9):911-6. doi: 10.1016/j.medengphy.2016.05.008. Epub 2016 Jun 6.

PMID:
27282530
6.

[Capsule endoscopy - small intestine finally a GKV approved procedure].

Hohn H.

Z Gastroenterol. 2014 Aug;52(8):1009-11. German. No abstract available.

PMID:
25250413
7.

[Position Paper of capsule endoscopy by the BNG -- part 1: small intestine].

Farnbacher M, Hohn H, Philipper M.

Z Gastroenterol. 2014 Apr;52(4):392-4. German. No abstract available.

PMID:
25006634
8.

Brief Distress Screening in Clinical Practice: Does it Help to Effectively Allocate Psycho-Oncological Support to Female Cancer Inpatients?

Hermelink K, Höhn H, Hasmüller S, Gallwas J, Härtl K, Würstlein R, Köhm J.

Breast Care (Basel). 2014 May;9(2):129-33. doi: 10.1159/000360788.

9.

Experimental and computational studies on the femoral fracture risk for advanced core decompression.

Tran TN, Warwas S, Haversath M, Classen T, Hohn HP, Jäger M, Kowalczyk W, Landgraeber S.

Clin Biomech (Bristol, Avon). 2014 Apr;29(4):412-7. doi: 10.1016/j.clinbiomech.2014.02.001. Epub 2014 Feb 14.

PMID:
24629519
10.

Stimulation of the greater occipital nerve: anatomical considerations and clinical implications.

Mueller O, Hagel V, Wrede K, Schlamann M, Hohn HP, Sure U, Gaul C.

Pain Physician. 2013 May-Jun;16(3):E181-9.

11.

Do we overestimate the endothelial cell "loss" after descemet membrane endothelial keratoplasty?

Quilendrino R, Höhn H, Tse WH, Chi H, Dapena I, Ham L, Oellerich S, Melles GR.

Curr Eye Res. 2013 Feb;38(2):260-5. doi: 10.3109/02713683.2012.753095. Epub 2013 Jan 7.

PMID:
23294140
12.

Advanced core decompression, a new treatment option of avascular necrosis of the femoral head--a first follow-up.

Landgraeber S, Theysohn JM, Classen T, Jäger M, Warwas S, Hohn HP, Kowalczyk W.

J Tissue Eng Regen Med. 2013 Nov;7(11):893-900. doi: 10.1002/term.1481. Epub 2012 Apr 4.

PMID:
22489064
13.

Is the alpine divide becoming more permeable to biological invasions? - Insights on the invasion and establishment of the Walnut Husk Fly, Rhagoletis completa (Diptera: Tephritidae) in Switzerland.

Aluja M, Guillén L, Rull J, Höhn H, Frey J, Graf B, Samietz J.

Bull Entomol Res. 2011 Aug;101(4):451-65. doi: 10.1017/S0007485311000010. Epub 2011 Feb 15.

PMID:
21320363
14.

Vascular wall-resident stem cells.

Klein D, Hohn HP, Kleff V, Tilki D, Ergün S.

Histol Histopathol. 2010 May;25(5):681-9. doi: 10.14670/HH-25.681. Review.

PMID:
20238305
15.

Emerging biology of vascular wall progenitor cells in health and disease.

Tilki D, Hohn HP, Ergün B, Rafii S, Ergün S.

Trends Mol Med. 2009 Nov;15(11):501-9. doi: 10.1016/j.molmed.2009.09.004. Epub 2009 Oct 12. Review.

PMID:
19828379
16.

Endothelial and hematopoietic progenitor cells (EPCs and HPCs): hand in hand fate determining partners for cancer cells.

Ergün S, Hohn HP, Kilic N, Singer BB, Tilki D.

Stem Cell Rev. 2008 Sep;4(3):169-77. doi: 10.1007/s12015-008-9028-y. Epub 2008 Jul 8. Review.

PMID:
18607782
17.

Potential implications of vascular wall resident endothelial progenitor cells.

Ergün S, Tilki D, Hohn HP, Gehling U, Kilic N.

Thromb Haemost. 2007 Nov;98(5):930-9. Review.

PMID:
18000595
18.
19.

MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.

Höhn H, Kortsik C, Zehbe I, Hitzler WE, Kayser K, Freitag K, Neukirch C, Andersen P, Doherty TM, Maeurer M.

Scand J Immunol. 2007 May;65(5):467-78.

20.

Influences of extracellular matrix and of conditioned media on differentiation and invasiveness of trophoblast stem cells.

Lei T, Hohn HP, Behr R, Denker HW.

Placenta. 2007 Jan;28(1):14-21. Epub 2006 Mar 24.

PMID:
16563500
21.

Differential MHC class II component expression in HPV-positive cervical cancer cells: implication for immune surveillance.

Zehbe I, Höhn H, Pilch H, Neukirch C, Freitag K, Maeurer MJ.

Int J Cancer. 2005 Dec 10;117(5):807-15.

22.

Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection.

Tully G, Kortsik C, Höhn H, Zehbe I, Hitzler WE, Neukirch C, Freitag K, Kayser K, Maeurer MJ.

J Immunol. 2005 Feb 15;174(4):2174-84.

23.

Naturally processed and HLA-B8-presented HPV16 E7 epitope recognized by T cells from patients with cervical cancer.

Oerke S, Höhn H, Zehbe I, Pilch H, Schicketanz KH, Hitzler WE, Neukirch C, Freitag K, Maeurer MJ.

Int J Cancer. 2005 May 1;114(5):766-78.

24.

Blood T-cell Vbeta transcriptome in melanoma patients.

Degauque N, Schadendorf D, Brouard S, Guillet M, Sébille F, Höhn H, Pallier A, Ruiz C, Dupont A, Chapin S, Hofmann U, Maeurer M, Soulillou JP.

Int J Cancer. 2004 Jul 10;110(5):721-9.

25.
26.
27.

Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.

Nilges K, Höhn H, Pilch H, Neukirch C, Freitag K, Talbot PJ, Maeurer MJ.

J Virol. 2003 May;77(9):5464-74.

28.

Definition of the HLA-A2 restricted peptides recognized by human CD8+ effector T cells by flow-assisted sorting of the CD8+ CD45RA+ CD28- T cell subpopulation.

Höhn H, Jülch M, Pilch H, Kortsik C, Tully G, Neukirch C, Freitag K, Maeurer M.

Clin Exp Immunol. 2003 Jan;131(1):102-10.

29.

Experimental modulation of cell-cell adhesion, invasiveness and differentiation in trophoblast cells.

Hohn HP, Denker HW.

Cells Tissues Organs. 2002;172(3):218-36. Review.

PMID:
12476050
30.

Image archives, audio- and video-sequences for teleteaching.

Höhn H, Esser W, Hamm H, Albert J.

Curr Probl Dermatol. 2003;32:191-4. No abstract available.

PMID:
12472011
31.

Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen.

Höhn H, Neukirch C, Freitag K, Necker A, Hitzler W, Seliger B, Maeurer MJ.

Clin Exp Immunol. 2002 Aug;129(2):309-17.

32.

Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.

Jäger E, Höhn H, Necker A, Förster R, Karbach J, Freitag K, Neukirch C, Castelli C, Salter RD, Knuth A, Maeurer MJ.

Int J Cancer. 2002 Mar 20;98(3):376-88.

33.

Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.

Jäger E, Salter R, Castelli C, Höhn H, Freitag K, Karbach J, Neukirch C, Necker A, Knuth A, Maeurer MJ.

J Immunol. 2002 Mar 15;168(6):2766-72.

34.

Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor.

Pilch H, Höhn H, Neukirch C, Freitag K, Knapstein PG, Tanner B, Maeurer MJ.

Clin Diagn Lab Immunol. 2002 Mar;9(2):267-78.

35.

Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis.

Pilch H, Höhn H, Freitag K, Neukirch C, Necker A, Haddad P, Tanner B, Knapstein PG, Maeurer MJ.

Clin Diagn Lab Immunol. 2002 Mar;9(2):257-66.

36.

Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue.

Maeurer MJ, Necker A, Salter RD, Castelli C, Höhn H, Karbach J, Freitag K, Neukirch C, Knuth A, Jäger E.

Int J Cancer. 2002 Jan 1;97(1):64-71.

38.

Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection.

Seitzer U, Kayser K, Höhn H, Entzian P, Wacker HH, Ploetz S, Flad HD, Gerdes J, Maeurer MJ.

Immunology. 2001 Nov;104(3):269-77.

39.

Antigen recognition by T cells: a strong sense of structure.

Maeurer M, Höhn H, Castelli C, Salter RD, Necker A, Reichert T, Knuth A, Jäger E.

Trends Immunol. 2001 Nov;22(11):599-601. No abstract available.

PMID:
11698218
40.

[Cholinergic syndrome with loss of consciousness in toadstool mushroom poisoning].

Hohn H.

Dtsch Med Wochenschr. 2001 Apr 27;126(17):512. German. No abstract available.

PMID:
11370598
41.

[Cholinergic syndrome with unconsciousness in amanita poisoning].

Hohn H, Schoenemann J.

Dtsch Med Wochenschr. 2000 Nov 10;125(45):1366-8. German.

PMID:
11109425
42.
43.

Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer.

Höhn H, Pilch H, Günzel S, Neukirch C, Freitag K, Necker A, Maeurer MJ.

J Virol. 2000 Jul;74(14):6632-6.

44.

Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides.

Jäger E, Maeurer M, Höhn H, Karbach J, Jäger D, Zidianakis Z, Bakhshandeh-Bath A, Orth J, Neukirch C, Necker A, Reichert TE, Knuth A.

Int J Cancer. 2000 May 15;86(4):538-47.

45.

CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7.

Höhn H, Pilch H, Günzel S, Neukirch C, Hilmes C, Kaufmann A, Seliger B, Maeurer MJ.

J Immunol. 1999 Nov 15;163(10):5715-22.

46.

[Low-dosage dental CT].

Rustemeyer P, Streubühr U, Hohn HP, Rustemeyer R, Eich HT, John-Mikolajewski V, Müller RD.

Rofo. 1999 Aug;171(2):130-5. German.

PMID:
10506887
47.

Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A.

Jäger E, Höhn H, Karbach J, Momburg F, Castelli C, Knuth A, Seliger B, Maeurer MJ.

Int J Cancer. 1999 Jun 11;81(6):979-84.

48.
49.
50.

Differentiation markers and invasiveness: discordant regulation in normal trophoblast and choriocarcinoma cells.

Hohn HP, Linke M, Ugele B, Denker HW.

Exp Cell Res. 1998 Oct 10;244(1):249-58.

PMID:
9770367

Supplemental Content

Support Center